Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer
Background: Upfront surgery followed by systemic treatment is recommended to treat clinical stage I–IIA small cell lung cancer (SCLC), but data on the clinical outcomes are sparse. Thus, this study evaluated the stage migration and long-term prognosis of surgically treated clinical stage I–IIA SC...
Main Authors: | Hyeok Sang Woo, Jae Won Song, Samina Park, In Kyu Park, Chang Hyun Kang, Young Tae Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Thoracic & Cardiovascular Surgery
2022-12-01
|
Series: | Journal of Chest Surgery |
Subjects: |
Similar Items
-
Survival analysis of Stage IIA1 and IIA2 cervical cancer patients
by: Jerry Cheng-Yen Lai, et al.
Published: (2013-03-01) -
Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
by: Chul-Hyo Jeon, et al.
Published: (2019-10-01) -
Differential impacts of clinical variables and 5-fluorouracil-based adjuvant chemotherapy on 5-year disease-free survival of patients with stage IIa and IIb colon cancer
by: Yi-Hung Kuo, et al.
Published: (2018-01-01) -
Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
by: Huapyong Kang, et al.
Published: (2022-09-01) -
Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC
by: Shengzu PENG, et al.
Published: (2017-06-01)